| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Silo Pharma, Inc. | Chief Financial Officer | Options (right to buy) | 55,000 | 23 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SILO | Silo Pharma, Inc. | 23 May 2025 | 1 | $0 | 4 | Chief Financial Officer | 27 May 2025, 19:02 |
| SILO | Silo Pharma, Inc. | 26 May 2023 | 1 | $2,126 | 4 | Chief Financial Officer | 26 May 2023, 16:17 |
| SILO | Silo Pharma, Inc. | 27 Sep 2022 | 0 | $0 | 3 | Chief Financial Officer | 04 Oct 2022, 21:12 |